Structure |
Chemical Name |
CAS |
MF |
|
2,1-BENZISOXAZOLE |
271-58-9 |
C7H5NO |
|
2,4-DICHLOROQUINOLINE |
703-61-7 |
C9H5Cl2N |
|
tert-butyl (R)-1-amino-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate |
|
|
|
(Trans)-tert-butyl 4-oxohexahydro-2H-pyrano[3,2-c]pyridine-6(7H)-carboxylate |
2177266-88-3 |
C13H21NO4 |
|
(3S,4S,5S)-Oseltamivir |
|
|
|
Pyrido[2,3-d]pyrimidin-4(3H)-one, 2-chloro- |
93049-38-8 |
C7H4ClN3O |
|
Edoxaban Impurity 19 (1S,2R,4S) Mesylate |
1807315-98-5 |
C17H26ClN5O6S |
|
(9H-fluoren-9-yl)methyl (R)-(4-cyclohexyl-1-(methylamino)-1-oxobutan-2-yl)carbamate |
|
|
|
4H-Pyrrolo[3,2-d]pyrimidin-4-one, 2-chloro-3,5-dihydro-3-methyl- |
2351929-82-1 |
C7H6ClN3O |
|
1-Pyrrolidinecarboxylic acid, 3-(4-bromo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester, (3R)- |
2198312-46-6 |
C12H18BrN3O2 |
|
1-BOC-3-(METHOXY)AZETIDINE |
429669-07-8 |
C9H17NO3 |
|
3-(3'-TRIFLUOROMETHYL PHENYL) PROPANOL |
78573-45-2 |
C10H11F3O |
|
5-Mercapto-1H-tetrazole-1-methane sulphonic acid |
67146-22-9 |
C2H4N4O3S2 |
|
2-(4-METHOXY-BENZYL)-2H-PYRAZOL-3-YLAMINE |
3528-45-8 |
C11H13N3O |
|
Ozagrel sodium |
130952-46-4 |
C13H13N2NaO2 |
|
N'-Hydroxy-2-(pyrrolidin-1-yl)benzimidamide |
|
C11H15N3O |
|
2’,3’-dideoxy-2’,3’-didehydroinosine |
|
|
|
Fmoc-Ala-Ala-Asn-PABC-PNP |
1834516-06-1 |
C39H38N6O11 |
|
2-Isopropoxy-5-methyl-4-(piperidin-4-yl)aniline dihydrochloride hydrate |
1802250-63-0 |
C15H27ClN2O2 |
|
MK-4618 Pyrimidinone Acid Sodium Salt |
1421271-01-3 |
C8H9N2NaO3 |
|
4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylbenzoic acid |
864725-62-2 |
C18H12Cl2F3NO3 |
|
4-Pyrimidinamine, 2-chloro-N-[2-[(1-methylethyl)sulfonyl]phenyl]- |
1197956-18-5 |
C13H14ClN3O2S |
|
-- |
93360-08-8 |
C30H27N2O6P |
|
Tadanafil intermediate (chloroacetyl porphyrin) |
171596-59-1 |
C31H57BN4O6Si |
|
4-acetyl-2-methylbenzoic acid |
55860-35-0 |
C10H10O3 |
|
6-BROMO-4-HYDROXYCOUMARIN |
4139-61-1 |
C9H5BrO3 |
|
ETHYL 5-ISOPROPYL-3-METHYLISOXAZOLE-4-CARBOXYLATE |
357326-79-5 |
C10H15NO3 |
|
7-DEAZA-2'-DEOXYINOSINE |
97224-58-3 |
C11H13N3O4 |
|
3-Iodo-1-(1-methyl-piperidin-4-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine |
1411763-96-6 |
C12H17IN6 |
|
Ethyl 6,8-dichlorooctanoate |
1070-64-0 |
C10H18Cl2O2 |
|
5-Methyl-3-phenylisoxazole-4-carbonyl chloride |
16883-16-2 |
C11H8ClNO2 |
|
2-(3,5-Dichlorophenyl)Pyrrolidine |
887344-13-0 |
C10H11Cl2N |
|
4S-fluoropyrrolidine-2R-carboxylic acid methyl ester hydrochloride salt |
131176-03-9 |
C6H11ClFNO2 |
|
3-Ethynyl-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
1189793-01-8 |
C10H11N5 |
|
LOXO-292 |
2222755-14-6 |
C29H31N9O3 |
|
1-Piperazinecarboxylic acid, 2-methyl-5-[[(3R)-3-methyl-4-morpholinyl]methyl]-, 1,1-dimethylethyl ester, (2R,5S)- |
1403902-78-2 |
C16H31N3O3 |
|
2-(2-Bromophenyl)pyrrolidine |
129540-24-5 |
C10H12BrN |
|
7-Methyl-1-tetralone |
22009-37-6 |
C11H12O |
|
PROSTAGLANDIN J2 |
60203-57-8 |
C20H30O4 |
|
methyl 2-(piperidin-4-yl)-1H-benzo[d]imidazole-5-carboxylate |
|
C14H17N3O2 |
|
1-(tert-butyl) 4-ethyl (3R,4R)-3-hydroxypiperidine-1,4-dicarboxylate |
206111-36-6 |
C13H23NO5 |
|
7 8-DIHYDROXY-4-PHENYLCOUMARIN |
842-01-3 |
C15H10O4 |
|
1,4-dihydroxy-2naphthoic acid methyl ester |
77060-74-3 |
C12H10O4 |
|
2’-deoxyinosine |
|
|
|
Anti-Ceftriaxong |
|
|
|
(R)-2-((trifluoromethoxy)methyl)piperazine |
|
|
|
benzyl (R)-2-(2,2-difluoroethyl)piperazine-1-carboxylate |
|
|
|
tert-butyl (S)-2-((trifluoromethoxy)methyl)piperazine-1-carboxylate |
|
|
|
tert-butyl (S)-2-(2,2,2-trifluoroethyl)piperazine-1-carboxylate |
1240582-25-5 |
C11H19F3N2O2 |
|
N6-[(5-Bromothien-2-yl)methyl]adenosine |
1706525-09-8 |
C15H16BrN5O4S |
|
4-hydroxy-6H-coumarin |
213481-01-7 |
C15H15NO3 |
|
1-Azetidinecarboxylic acid, 3-(4-iodo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester |
951259-19-1 |
C11H16IN3O2 |
|
Cefuroxime Impurity 1(Cefuroxime Mother Nucleus) |
|
|
|
methyl 6-amino-7-fluoro-3H-benzimidazole-5-carboxylate |
918321-29-6 |
C9H8FN3O2 |
|
(2S,4R)-4-BOC-AMINO PYRROLIDINE-2-CARBOXYLIC ACID METHYLESTER-HCL |
913742-54-8 |
C11H21ClN2O4 |
|
2-(Ethylsulfonyl)-5-(1-piperidinyl)aniline |
1220021-52-2 |
C13H20N2O2S |
|
4-Chloro-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline |
264208-72-2 |
C16H20ClN3O2 |
|
(E)-3-[2-(Pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amine |
886230-76-8 |
C19H20N4O |
|
(S)-(2-Aminomethyl)-1-N-Boc-pyrrolidine HCl |
1190890-11-9 |
C10H21ClN2O2 |
|
3',5'-di-o-acetyl-2-deoxy-5-azacytosine |
22432-93-5 |
C12H16N4O6 |
|
(2S,4S)-1-(tert-Butoxycarbonyl)-4-fluoro-2-hydroxymethylpyrrolidine |
317356-27-7 |
C10H18FNO3 |
|
5-(4-Bromophenyl)-4,6-dichloropyrimidine |
146533-41-7 |
C10H5BrCl2N2 |
|
2-Propenoic acid, 3-(5-nitro-1-cyclohexen-1-yl)-, (2E)- |
899809-64-4 |
C9H11NO4 |
|
Aegelin |
456-12-2 |
C18H19NO3 |
|
1,2,4-cyclohexanetricarboxylic anhydride |
53611-01-1 |
C9H10O5 |
|
(3R,4S)-tert-butyl 3,4-dihydroxypyrrolidine-1-carboxylate |
186393-22-6 |
C9H17NO4 |
|
3,4-Diethyl 2-aMinothiophene-3,4-dicarboxylate |
104680-25-3 |
C10H13NO4S |
|
1-(4-(3-Methoxy-4-nitrophenyl)piperazin-1-yl)ethanone |
1116229-11-8 |
C13H17N3O4 |
|
Methyl (R)-4,4-difluoropyrrolidine-2-carboxylate hydrochloride |
1408057-39-5 |
C6H10ClF2NO2 |
|
R 5011 (dopant) |
944537-61-5 |
C32H34O2 |
|
N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride |
1260590-51-9 |
C13H20ClN5 |
|
3-(Benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid |
119736-16-2 |
C13H10O5 |
|
SELEXIPAG interMediate |
475086-75-0 |
C23H27N3O |
|
O-Methyl Dolutegravir |
1335210-35-9 |
C21H21F2N3O5 |
|
2-PhenylpyriMidine-4-carboxylic acid |
16879-53-1 |
C11H8N2O2 |
|
Ethyl 2-chloropyrazolo[1,5-a]pyriMidine-3-carboxylate |
1394003-65-6 |
C9H8ClN3O2 |
|
tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl]carbaMate |
1172623-99-2 |
C16H21F2NO4 |
|
N,N-Diphenyl-1H-imidazole-1-carboxamide |
2875-79-8 |
C16H13N3O |
|
Pyrazolam |
39243-02-2 |
C16H12BrN5 |
|
Coumarin |
10172-76-6 |
C27H21NO6 |
|
4-(1-Fluoro-1-methyl-ethyl)-pyrimidine-5-carbaldehyde |
1427195-14-9 |
C8H9FN2O |
|
4-(3-(allyloxymethyl)phenyl)-2-chloropyrimidine |
937273-29-5 |
C14H13ClN2O |
|
2-(tert-butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid |
851784-82-2 |
C15H17Cl2NO4 |
|
Pemetrexed intermediate |
|
|
|
(2S,5S)-ethyl 5-methylpyrrolidine-2-carboxylate 2,2,2-
trifluoro acetate salt |
676560-85-3 |
C10H16F3NO4 |
|
3-bromodibenzo[b,d]thiophene |
97511-04-1 |
C12H7BrS |
|
,100kg |
180048-73-1 |
C11H14O4S |
|
1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydrochloride |
156077-56-4 |
C12H29ClN4O3 |
|
tert-butyl 4-(4-bromothiazol-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate |
1332301-87-7 |
C13H17BrN2O2S |
|
PPAP |
784118-64-5 |
C14H23N |
|
Cefmetazole Impurity 4 |
68576-47-6 |
C15H17N7O4S4 |
|
Otilonium Bromide intermediates |
51444-79-2 |
C22H27NO4 |
|
2,5-Piperazinedione, 1-acetyl-3-(phenylmethylene)-, (3Z)- |
30166-30-4 |
C13H12N2O3 |
|
(5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-5-phenyl-2-pyrrolidinone |
1027552-46-0 |
C21H22FNO3 |
|
4F-MPH |
1354631-33-6 |
C14H18FNO2 |
|
Oseltamivir-13CD3 |
1093851-61-6 |
C16H28N2O4 |
|
3,5-Dibromo-1H-pyrazole |
67460-86-0 |
C3H2Br2N2 |
|
tert-butyl (3R,4S,5S)-4-((S)-2-amino-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoate |
177423-00-6 |
C19H38N2O4 |
|
tert-butyl 6-bromo-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-1-carboxylate |
1403901-49-4 |
C14H19BrN2O2 |
|
2H-1-Benzopyran-2-one, 6-chloro-4-methyl- |
24145-78-6 |
C10H7ClO2 |